Zobrazeno 1 - 10
of 176
pro vyhledávání: '"V. Rovei"'
Autor:
A. Graziottin, V. Rovei
Publikováno v:
Sexologies. 16:292-298
Breast cancer (BC) may affect three main domains of women's sexuality: sexual identity, sexual function and sexual relationship. Age, lymphedema, side-effects of surgery, radio-, chemo- and hormonotherapy, pregnancy-related problems, infertility, iat
Publikováno v:
Experiment. 2:253-275
Befloxatone, a novel oxazolidinone derivative, inhibited selectively and competitively monoamine oxidase (MAO)-A in human and rat brain, heart, liver and duodenum homogenates with Ki values ranging from 1.9 to 3.6 nM for MAO-A and from 270 to 900 nM
Publikováno v:
Xenobiotica. 23:181-191
1. An analytical method for the simultaneous determination of three major metabolites of antipyrine, namely, 3-hydroxymethylantipyrine (phase I), 4-hydroxyantipyrine sulphoconjugate (phase II) and norantipyrine sulphoconjugate (phase II) in cultured
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 277(1)
Befloxatone, a novel oxazolidinone derivative, inhibited selectively and competitively monoamine oxidase (MAO)-A in human and rat brain, heart, liver and duodenum homogenates with Ki values ranging from 1.9 to 3.6 nM for MAO-A and from 270 to 900 nM
Autor:
D, Caille, O E, Bergis, C, Fankhauser, A, Gardes, R, Adam, T, Charieras, A, Grosset, V, Rovei, F X, Jarreau
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 277(1)
The pharmacological profile of befloxatone, a reversible, selective and competitive inhibitor of monoamine oxidase-A has been investigated in rodents. In mice, befloxatone was more active at potentiating generalized tremors induced by L-5-hydroxytryp
Publikováno v:
Journal of neural transmission. Supplementum. 41
In vitro and ex-vivo studies show that befloxatone, a new oxazolidinone derivative, is a potent, reversible, competitive and specific MAO-A inhibitor (KiA from 1.9 to 3.6 nM and KiB/KiA ratio between 100 and 400, in the Rat and in Man, depending on t
Publikováno v:
Amine Oxidases: Function and Dysfunction ISBN: 9783211825211
In vitro and ex-vivo studies show that befloxatone, a new oxazolidinone derivative, is a potent, reversible, competitive and specific MAO-A inhibitor (KiA from 1.9 to 3.6 nM and KiB/KiA ratio between 100 and 400, in the Rat and in Man, depending on t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a217261cc2b39f16352d08f81ffc5d0
https://doi.org/10.1007/978-3-7091-9324-2_45
https://doi.org/10.1007/978-3-7091-9324-2_45
Publikováno v:
Biological Psychiatry. 43:S38
Publikováno v:
Clinical Neuropharmacology. 15:551B